Proteomics Intl Labs Ltd has released a press release.
PromarkerD Development Advances in China
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Later from Proteomics International Laboratories
- Appendix 4C - June 2016 Quarterly Report
- Proteomics first commercialisation deal for PromarkerD
- Proteomics expands diagnostics portfolio to endometriosis
- Proteomics investigates biomarkers for mesothelioma
- Proteomics International receives FY16 R&D Tax Incentive
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories